- Companies
- Sky Labs
Sky Labs Valuation Multiples
Sky Labs is valued at $98M as of November 2026, a 16.5x revenue multiple. In the last fiscal year, Sky Labs revenue was $6M and Sky Labs EBITDA was ($42M).
Sky Labs Overview
About Sky Labs
Sky Labs Inc is engaged in the business of development, manufacturing, and sales of wearable medical devices and data platforms capable of continuously measuring and analyzing the vital signs of patients with chronic diseases even in non-hospital environments. Its flagship product is 'CART BP pro,' a cuffless ring-type blood pressure monitoring device. Based on a PPG sensor, it measures blood pressure and transmits data to the cloud, which is utilized by medical professionals for diagnosis and patient management. Its product solutions are a photoplethysmography (PPG) sensor, a deep learning algorithm, Automatic blood pressure measurement, and Various platforms.
Founded
2015
HQ
Employees
N/A
Website
Financials (Last FY)
EV
$98M
Valuation Multiples
Start free trialSky Labs Financials
Sky Labs reported last fiscal year revenue of $6M and negative EBITDA of ($42M).
In the same fiscal year, Sky Labs generated $3M in gross profit, ($42M) in EBITDA losses, and had net loss of ($47M).
Sky Labs P&L
In the most recent fiscal year, Sky Labs reported revenue of $6M and EBITDA of ($42M).
Sky Labs is unprofitable as of last fiscal year, with gross margin of 49%, EBITDA margin of (706%), and net margin of (794%).
Financial data powered by Morningstar, Inc.
Sky Labs Stock Performance
Sky Labs has current market cap of $98M, and enterprise value of $98M.
Market Cap Evolution
Sky Labs' stock price is $5.22.
Sky Labs has an EPS (earnings per share) of $-2.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $98M | $98M | 1.5% | - | - | - | $-2.52 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSky Labs Valuation Multiples
Sky Labs trades at 16.5x EV/Revenue multiple, and (2.3x) EV/EBITDA.
Sky Labs Financial Valuation Multiples
As of November 19, 2026, Sky Labs has market cap of $98M and EV of $98M.
Sky Labs has a P/E ratio of (2.1x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sky Labs Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Sky Labs Margins & Growth Rates
Sky Labs grew revenue by 29% but net profit decreased by 76% in the last fiscal year.
In the most recent fiscal year, Sky Labs reported gross margin of 49%, EBITDA margin of (706%), and net margin of (794%).
Sky Labs Margins
Sky Labs Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Sky Labs Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Sky Labs Competitors
Sky Labs competitors include Viromed Medical, Cumberland, Optiscan Imaging, Quanterix, Onyx Healthcare, Sisram Medical, Vivani Medical, MEZOO, Perspective Therapeutics and Guerbet.
Most Sky Labs public comparables operate across Wearables, Medical Devices and BioTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $6M | ($377K) | 17.4x | 9.3x | (258.6x) | 62.9x | |||
| $45M | $2M | 0.5x | - | 8.9x | - | |||
| $302K | ($5M) | 297.2x | - | (18.7x) | - | |||
| $139M | ($102M) | 0.4x | 0.4x | (0.5x) | (0.8x) | |||
| $40M | $4M | 2.3x | - | 20.9x | - | |||
| $365M | $48M | 0.4x | 0.4x | 2.7x | 3.1x | |||
| - | ($26M) | - | - | (3.7x) | - | |||
| $5M | - | 17.3x | 17.3x | - | - | |||
This data is available for Pro users. Sign up to see all Sky Labs competitors and their valuation data. Start Free Trial | ||||||||
Sky Labs VC Funding History
Before going public, Sky Labs raised $42M in total equity funding, across 4 rounds.
Sky Labs Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sky Labs
| When was Sky Labs founded? | Sky Labs was founded in 2015. |
| Where is Sky Labs headquartered? | Sky Labs is headquartered in South Korea. |
| Is Sky Labs publicly listed? | Yes, Sky Labs is a public company listed on Korea Exchange. |
| What is the stock symbol of Sky Labs? | Sky Labs trades under 386380 ticker. |
| When did Sky Labs go public? | Sky Labs went public in 2026. |
| Who are competitors of Sky Labs? | Sky Labs main competitors include Viromed Medical, Cumberland, Optiscan Imaging, Quanterix, Onyx Healthcare, Sisram Medical, Vivani Medical, MEZOO, Perspective Therapeutics, Guerbet. |
| What is the current market cap of Sky Labs? | Sky Labs' current market cap is $98M. |
| What is the current revenue of Sky Labs? | Sky Labs' last fiscal year revenue is $6M. |
| What is the current revenue growth of Sky Labs? | Sky Labs revenue growth (vs. last FY) is 29%. |
| What is the current EV/Revenue multiple of Sky Labs? | Current revenue multiple of Sky Labs is 16.5x. |
| Is Sky Labs profitable? | No, Sky Labs is not profitable. |
| How many companies Sky Labs has acquired to date? | Sky Labs hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Sky Labs has invested to date? | Sky Labs hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Sky Labs
Lists including Sky Labs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




